Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California

被引：0
作者：
Paulo Telles Dias
Judith A Hahn
Eric Delwart
Brian R Edlin
Jeff Martin
Paula Lum
Jennifer Evans
Alex Kral
Steve Deeks
Michael P Busch
Kimberly Page
机构：
[1] Núcleo de Estudos e Pesquisas em Atenção ao Uso de Drogas (NEPAD)- Universidade do Estado do Rio de Janeiro (State University of Rio de Janeiro),Department of Epidemiology and Biostatistics, Division of Preventive Medicine and Public Health
[2] University of California San Francisco,Department of Medicine, Division of Infectious Disease, San Francisco General Hospital
[3] University of California San Francisco,Department of Medicine
[4] Blood Systems Research Institute,Department of Epidemiology and Biostatistics, Division of Clinical Epidemiology
[5] SUNY Downstate College of Medicine,Department of Medicine, Positive Health Program, San Francisco General Hospital
[6] University of California San Francisco,Department of Laboratory Medicine
[7] University of California San Francisco,undefined
[8] Research Triangle Institute (RTI),undefined
[9] University of California San Francisco,undefined
来源：
BMC Infectious Diseases | / 11卷
关键词：
hepatitis C virus; HCV; GT; injection drug use; HIV; birth cohort; African-American;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 378 条
  • [1] Simmonds P(2005)Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes Hepatology 42 962-973
  • [2] Bukh J(2002)Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N Engl J Med 347 975-982
  • [3] Combet C(2001)Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial Lancet 358 958-965
  • [4] Deleage G(2004)Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites N Engl J Med 350 2265-2271
  • [5] Enomoto N(1998)Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group [see comments] N Engl J Med 339 1485-1492
  • [6] Feinstone S(2000)The natural history of hepatitis C virus infection Journal of the American Medical Association 284 450-456
  • [7] Halfon P(2008)Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis Gastroenterology 134 416-423
  • [8] Inchauspe G(2005)Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease J Infect Dis 191 4-10
  • [9] Kuiken C(2000)Clinical significance of hepatitis C virus genotypes and quasispecies Semin Liver Dis 20 103-126
  • [10] Maertens G(2004)Differences in treatment outcome for hepatitis C among ethnic groups Am J Med 117 163-168
12345678910